0001209191-18-042389.txt : 20180711 0001209191-18-042389.hdr.sgml : 20180711 20180711180524 ACCESSION NUMBER: 0001209191-18-042389 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180709 FILED AS OF DATE: 20180711 DATE AS OF CHANGE: 20180711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cumbo Alexander CENTRAL INDEX KEY: 0001685994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 18949357 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-09 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001685994 Cumbo Alexander 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 SVP, Chief Commercial Officer Common Stock 2018-07-09 4 M 0 11924 13.71 A 40690 D Common Stock 2018-07-09 4 S 0 11924 137.32 D 28766 D Common Stock 2018-07-09 4 M 0 9944 13.71 A 38710 D Common Stock 2018-07-09 4 S 0 9944 137.32 D 28766 D Common Stock 2018-07-09 4 M 0 11914 13.90 A 40680 D Common Stock 2018-07-09 4 S 0 11914 137.32 D 28766 D Stock option (right to buy) 13.71 2018-07-09 4 M 0 11924 13.71 D 2017-02-28 2026-02-28 Common Stock 11924 3850 D Stock option (right to buy) 13.71 2018-07-09 4 M 0 9944 13.71 D 2017-02-28 2026-02-28 Common Stock 9944 3895 D Stock option (right to buy) 13.90 2018-07-09 4 M 0 11914 13.90 D 2016-02-27 2025-02-27 Common Stock 11914 2250 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 8, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/ David Tyronne Howton, as Attorney-in-Fact for Alexander Cumbo 2018-07-11